Back to search

Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: its relevance for treatment in established diabetes and islet transplantation

Data up to Jan 2025

Published2001
Citations26
References41

Total Citations Per Year

Abstract

References (41)

Reshaping human antibodies for therapy

1988 • 1,555 citations

CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

1994 • 862 citations

OKT3: A monoclonal anti-human T lymphocyte antibody with potent mitogenic properties

1980 • 718 citations

The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD

1997 • 685 citations

Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases.

1985 • 387 citations

RELEASE OF TUMOR NECROSIS FACTOR, INTERLEUKIN-2, AND GAMMA-INTERFERON IN SERUM AFTER INJECTION OF OKT3 MONOCLONAL ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS

1989 • 361 citations

T cell suppression in transplantation tolerance through linked recognition.

1996 • 246 citations

HOW DO MONOCLONAL ANTIBODIES INDUCE TOLERANCE? A Role for Infectious Tolerance?

1998 • 223 citations

The generation of a humanized, non‐mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

1993 • 217 citations

Spontaneous Diabetes Mellitus: Reversal and Prevention in the BB/W Rat with Antiserum to Rat Lymphocytes

1979 • 212 citations

Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.

1989 • 198 citations

Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.

1999 • 183 citations

Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.

1988 • 141 citations

PHASE I STUDY OF AN ENGINEERED AGLYCOSYLATED HUMANIZED CD3 ANTIBODY IN RENAL TRANSPLANT REJECTION1

1999 • 140 citations

Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors.

1993 • 127 citations

In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A.

1993 • 124 citations

ANTI-CD3 F(abʼ)2 FRAGMENTS ARE IMMUNOSUPPRESSIVE IN VIVO WITHOUT EVOKING EITHER THE STRONG HUMORAL RESPONSE OR MORBIDITY ASSOCIATED WITH WHOLE mAb

1990 • 124 citations

Insulin-dependent diabetes mellitus as an autoimmune disease

1994 • 103 citations

Spontaneous Diabetes in Rats: Destruction of Islets Is Prevented by Immunological Tolerance

1981 • 101 citations

Induction of T cell proliferation with anti‐CD3 switch‐variant monoclonal antibodies: effects of heavy chain isotype in monocyte‐dependent systems

1987 • 90 citations

Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.

1971 • 86 citations

Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.

1997 • 85 citations

In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products.

1985 • 79 citations

Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats

2000 • 78 citations

Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.

1996 • 72 citations

Induction of T helper cell hyporesponsiveness in an experimental model of autoimmunity by using nonmitogenic anti-CD3 monoclonal antibody.

1994 • 72 citations

Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb

1994 • 71 citations

Curing BB rats of freshly manifested diabetes by short‐term treatment with a combination of a monoclonal anti‐interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A

1987 • 57 citations

Type-I Diabetes: A Chronic Autoimmune Disease Of Human, Mouse, And Rat

1990 • 47 citations

Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat.

1999 • 47 citations

Long-term function (6 years) of islet allografts in type 1 diabetes

1997 • 39 citations

Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo.

1990 • 39 citations

Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation.

1995 • 38 citations

Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.

1991 • 36 citations

Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody

1992 • 36 citations

Transplantation of pancreas and islets of Langerhans: a review of progress

1996 • 18 citations

Pancreas Transplantation

1999 • 10 citations

Islet transplantation in spontaneously diabetic BB/Wor rats

1989 • 4 citations

Recurrence of Autoimmune Diabetes Mellitus in Recipients of Cadaveric Pancreatic Grafts

1996 • 4 citations

Islet Cell Transplantation: Beyond the Paradigms

1996 • 3 citations

CONTRASTING IN VIVO EFFECTS ON T HELPER CELL FUNCTIONS INDUCED BY MITOGENIC (INTACT) VERSUS NONMITOGENIC (F(abʼ2) ANTI-CD3 MONOCLONAL ANTIBODY

1995 • 1 citations

Cited By (0)

No citing papers found in database

Restoration of self-tolerance is a feasible approach to control ongoing beta-cell… (2001) – Diabetologia | Metascience Observatory Explorer